Genprex and Roche Diagnostics to Validate TROP2 Biomarker Assays for Lung Cancer Trials
Genprex has announced a collaboration with Roche Diagnostics to validate TROP2 biomarker assays for patient selection in non small cell lung cancer clinical trials.